Загрузка...
Oral verapamil does not affect glucose tolerance in non-diabetics.
Verapamil, a calcium antagonist used to treat angina pectoris, inhibits insulin release in vitro and, when administered intravenously to humans, decreases glucose tolerance. Oral verapamil, 120 mg/day for 1 week increasing thereafter to 240 mg/day in divided doses, was given to nine non-diabetic pat...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1983
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1427712/ https://ncbi.nlm.nih.gov/pubmed/6860534 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|